Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Light Chain (AL) Amyloidosis, Stage 3B”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT07079423
What this trial is testing

Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis

Who this might be right for
AL Amyloidosis
Peking Union Medical College Hospital 35
Testing effectiveness (Phase 2)Study completedNCT04131309
What this trial is testing

Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis, Stage 3B
Stichting European Myeloma Network 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055724
What this trial is testing

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

Who this might be right for
AL Amyloidosis
Nanjing IASO Biotechnology Co., Ltd. 17
Large-scale testing (Phase 3)Active Not RecruitingNCT04504825
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 125

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation